MELBOURNE, AUSTRALIA: Cynata Therapeutics Limited has executed a Manufacturing Services Agreement (MSA) with FUJIFILM Cellular Dynamics, for the manufacture and supply of Cynata’s Cymerus therapeutic mesenchymal stem cell (MSC) products derived from induced pluripotent stem cells (iPSCs) for clinical trials and commercial applications.This new agreement was foreshadowed in the Strategic Partnership Agreement between FUJIFILM Corporation…